Pelvic exenteration for recurrent rectal cancer involving the small bowel and abdominal wall – case report

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Jun 30, 2014
DOI: https://doi.org/10.22551/2014.01.0101.10003
Bogdan Filip
1st Department of Surgical Unit, Regional Institute of Oncology Iasi, University of Medicine and Pharmacy „Grigore T. Popa”, Iasi, Romania
Ionut Hutanu Maria Gabriela Anitei Iulian Radu Viorel Scripcariu

Abstract

Pelvic exenteration represents a radical intervention performed on highly selected cases for locally advanced pelvic (gynecologic and digestive) tumours. Due to the high complexity of the intervention and of the impact of the neoplastic disease on the patient this intervention is accompanied by a high degree of postoperative morbidity. We hereby present the case of a patient with recurrent rectal cancer involving the bladder, small bowel and anterior abdominal wall in which a supralevatorial pelvectomy was performed. Although it was performed on a patient with infected tumour, the postoperative course of the patient was uneventful; the patient is disease-free at 6 months after pelvectomy. Although pelvic exenteration is associated with increased morbidity, many patients with recurrence after rectal resection that undergo this intervention can have increased disease-free survival.

##plugins.themes.bootstrap3.article.details##

Keywords

pelvic exenteration, rectal cancer, morbidity

References
1. Brunschwig A.: Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer, 1948, 1(2):177-83. Epub 1948/07/01.
2. Dias AR, Nahas SC: Modified supralevator pelvic exenteration for the treatment of locally advanced rectal cancer with vaginal and uterine invasion. Surg Today, 2013, 43(6):702-4. Epub 2012/08/22.
3. Averette HE, Lichtinger M, Sevin BU, Girtanner RE: Pelvic exenteration: a 15-year experience in a general metropolitan hospital. Am J Obst Gynecol, 1984, 150(2):179-84. Epub 1984/09/15.
4. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL: Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol, 1989, 35(1):93-8. Epub 1989/10/01.
5. Houvenaeghel G. [Conservative surgery and restoration after pelvic exenteration]. Bulletin du cancer. 2002, 89(12):1061-6. Epub 2003/01/15. Chirurgie de preservation d'organes et de restauration apres exenteration pelvienne.
6. Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD: Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Col Rect, 2003, 46(12):1619-25. Epub 2003/12/12.
7. Meterissian SH, Skibber JM, Giacco GG, el-Naggar AK, Hess KR, Rich TA: Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery, 1997, 121(5):479-87. Epub 1997/05/01.
8. Russo P, Ravindran B, Katz J, Paty P, Guillem J, Cohen AM: Urinary diversion after total pelvic exenteration for rectal cancer. Ann Surg Oncol, 1999, 6(8):732-8. Epub 2000/01/06.
9. Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S: Outcome of total pelvic exenteration for locally recurrent rectal cancer. Hepatogastroenterology, 2003, 50(51):700-3. Epub 2003/06/28.
10. Vermaas M, Ferenschild FT, Verhoef C et al.: Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol, 2007, 33(4):452-8. Epub 2006/10/31.
11. Gannon CJ, Zager JS, Chang GJ et al.: Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol, 2007, 14(6):1870-7. Epub 2007/04/05.
12. Wells BJ, Stotland P, Ko MA et al. Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol, 2007, 14(2):390-5. Epub 2006/10/26.
13. Domes TS, Colquhoun PH, Taylor B, Izawa JI, House AA, Luke PP: Total pelvic exenteration for rectal cancer: outcomes and prognostic factors. Can J Surg, 2011, 54(6):387-93. Epub 2011/09/24.
14. Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S: Outcome of total pelvic exenteration for primary rectal cancer. Dis Col Rect, 2003, 46(4):474-80. Epub 2003/04/12.
15. Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K.: Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Col Rect, 2004, 47(12):2055-63. Epub 2005/01/20.
How to Cite
Filip, B., Hutanu, I., Anitei, M. G., Radu, I., & Scripcariu, V. (2014). Pelvic exenteration for recurrent rectal cancer involving the small bowel and abdominal wall – case report. Archive of Clinical Cases, 1(1), Arch Clin Cases 2014; 1(1):9-12. https://doi.org/10.22551/2014.01.0101.10003
Issue
Vol. 1 No. 1 (2014)
Section
Case Reports

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.

Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.

How to Cite

Filip, B., Hutanu, I., Anitei, M. G., Radu, I., & Scripcariu, V. (2014). Pelvic exenteration for recurrent rectal cancer involving the small bowel and abdominal wall – case report. Archive of Clinical Cases, 1(1), Arch Clin Cases 2014; 1(1):9-12. https://doi.org/10.22551/2014.01.0101.10003